The hidden biochemistry of insulin resistance: why a standard blood-sugar test misleads
Dr Sergey Saadi
Most people assume that if their fasting glucose is normal (below 5.6 mmol/L), their carbohydrate metabolism is perfectly healthy. This is a dangerous myth. Type-2 diabetes and metabolic syndrome develop silently for 10–15 years before blood sugar ever starts rising.
Compensatory hyperinsulinaemia: the silent phase
How does it happen? As cellular resistance develops, the pancreas is forced to produce ever-larger amounts of insulin to push glucose into cells. This state – compensatory hyperinsulinaemia – can persist for decades without any abnormality in glucose readings (DeFronzo, Diabetes Care 2009; Petersen & Shulman, Physiol Rev 2018).
Blood sugar stays perfect, but chronically high insulin blocks lipolysis, causes fat accumulation around the waist, damages the vascular endothelium, promotes dry skin, acanthosis nigricans, and constant afternoon fatigue after carb-rich meals.
Why HbA1c and fasting glucose miss 60% of undiagnosed cases
Kraft (1975, later replicated by Crofts & Schofield, BMJ Open Diabetes 2016) showed that a 5-hour oral glucose tolerance test with insulin measurement detects insulin resistance in about 75% of participants whose glucose is ‘normal’. Fasting glucose and HbA1c only rise once beta-cell reserve has been exhausted.
- Fasting glucose < 5.6 mmol/L ≠ healthy metabolism
- HbA1c < 5.7% does not rule out hyperinsulinaemia
- Insulin typically rises 5–10 years before glucose
- Visceral fat can accumulate in normal-weight people (TOFI – thin outside, fat inside)
Diagnosis: HOMA-IR and fasting insulin
Glucose alone is not enough. Fasting insulin must be measured and the HOMA-IR index calculated: (glucose mmol/L × insulin mU/L) / 22.5. Other valuable markers include the triglyceride/HDL ratio (> 1.5 suggests insulin resistance), fasting C-peptide and waist circumference.
- HOMA-IR optimal functional level: < 1.0
- HOMA-IR 1.0–1.9: subclinical resistance, lifestyle intervention needed
- HOMA-IR > 1.9: active insulin resistance
- Fasting insulin > 10 mU/L: warning signal
"Insulin is the hormone that stores energy. Chronically high insulin means the body is locked in storage mode – even when you are not eating."
The 5 main root causes of insulin resistance
- Visceral fat – releases inflammatory adipokines that block insulin signalling
- Chronic eating window > 14 h/day – beta cells get no rest
- Non-alcoholic fatty liver disease (NAFLD) – about 25% of adults per Younossi et al., Hepatology 2019
- Chronic sleep debt – a single bad night reduces insulin sensitivity ~25% (Donga et al., JCEM 2010)
- Inactivity and low muscle mass – fewer GLUT4 transporters in skeletal muscle
Practical reversal protocol
- Eating window 10–12 h, last meal at least 3 h before sleep
- Carbs mainly during active periods, not in the evening
- 10–15 min walk after each main meal – Reynolds, Diabetologia 2016
- Strength training 2–3× per week, even short sessions work
- Magnesium and vitamin D – the need and dose are decided by a doctor based on tests
- Polyphenol-rich Mediterranean pattern: olive oil, berries, fish, legumes
Read the full article
Enter your email and the full text opens right here on this page.
Scientific references
- [1]DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes (Diabetes), 2009
- [2]Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance (Physiological Reviews), 2018
- [3]Crofts CAP, et al. Identifying hyperinsulinaemia in the absence of impaired glucose tolerance (BMJ Open Diabetes Research & Care), 2016
- [4]Donga E, et al. A single night of partial sleep deprivation induces insulin resistance (J Clin Endocrinol Metab), 2010
- [5]Morris CJ, et al. Endogenous circadian system and circadian misalignment impact glucose tolerance (J Clin Endocrinol Metab), 2015
- [6]Younossi ZM, et al. Global perspectives on nonalcoholic fatty liver disease (Hepatology), 2019
- [7]Zeevi D, et al. Personalized nutrition by prediction of glycemic responses (Cell), 2015
- [8]Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity – STEP 1 (NEJM), 2021
- [9]UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin – UKPDS 34 (Lancet), 1998